FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to hematology and oncology, and concerns correction of amegakaryocytic thrombocytopenia. That is ensured by introducing a platelet concentrate and performing autologous peripheral haemopoietic stem cell transplantation with performing a single subcutaneous injection of romiplostim 200-300 mcg on the day of the transplantation.
EFFECT: method provides reducing a risk of the haemorrhagic complications following the high-dose chemotherapy, ensured by the fast and effective platelet growth.
2 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING IMMUNE THROMBOCYTOPENIA | 2018 |
|
RU2703458C1 |
| METHOD FOR REDUCING TOXIC AND INFECTIOUS COMPLICATIONS IN THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA | 2020 |
|
RU2773740C2 |
| METHOD FOR TRANSPLANTATION OF PERIPHERAL BLOOD AUTOLOGOUS HAEMOPOIETIC STEM CELLS | 2019 |
|
RU2734121C1 |
| TEST SYSTEM AND METHODS OF DETERMINING BIOLOGICAL ACTIVITY OF HUMAN THROMBOPOETIN RECEPTOR AGONISTS | 2023 |
|
RU2810503C1 |
| METHOD OF TREATING MULTIPLE SCLEROSIS AND OTHER SYSTEMIC AUTOIMMUNE DISEASES | 2015 |
|
RU2600160C1 |
| METHOD FOR PREDICTION OF LETHAL OUTCOME FROM PNEUMONIA IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES AFTER HIGH-DOSAGE POLYCHEMOTHERAPY WITH TRANSPLANTATION OF AUTOLOGICAL HEMATOPOIETIC STEM CELLS | 2021 |
|
RU2770268C1 |
| METHOD FOR PREDICTING DISEASE-FREE SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION | 2015 |
|
RU2580648C1 |
| METHOD FOR PREDICTION OF EARLY RELAPSE IN PATIENTS WITH HAEMOBLASTOSES FOLLOWING AUTOLOGOUS STEM HAEMOPOIETIC CELL TRANSPLANTATION | 2012 |
|
RU2498312C1 |
| METHOD OF SURGICAL TREATMENT OF CHILDREN WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA | 2000 |
|
RU2168947C1 |
| METHOD FOR PREDICTION OF EARLY RECURRENCE IN PATIENTS WITH CLASSICAL HODGKIN'S LYMPHOMA | 2019 |
|
RU2702360C1 |
